Authors Gaoyang Liang and Ronald Evans (IMAGE)

Salk Institute

Authors Gaoyang Liang and Ronald Evans

Caption

Gaoyang Liang (left) and Ronald Evans (right) led a study that reveals how HDAC inhibitors help pancreatic tumors resist DNA damage and developed new therapeutic strategies based on HDAC inhibition.

Credit

Salk Institute

Usage Restrictions

With credit and related coverage

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.